MoneyWorks4Me

Ajanta Pharma informs about details of loss of certificate

07 Aug 2023 Evaluate
Pursuant to Regulation 39(3) of the SEBI LODR Regulations and in terms of SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022, Ajanta Pharma has informed that the Company has approved issuance of ‘Letter of Confirmation’ on 4th August 2023 in lieu of share certificate(s), which were reported lost by the shareholder: Paridhi Shah (Folio No. 000545)

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..